Related Experiment Video
Updated: Aug 2, 2026
11:44
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
[Identification and analysis of IRF-1 binding protein]
1Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|July 1, 1996
Summary
Interferon Regulatory Factor-1 (IRF-1) normally suppresses tumors. A protein identical to nucleophosmin (NPM) binds and inactivates IRF-1, potentially driving leukemia development.
Area of Science:
- Molecular Biology
- Oncology
- Virology
Context:
- Interferon Regulatory Factor-1 (IRF-1) is a crucial tumor suppressor and transcriptional activator in the interferon system.
- Loss of functional IRF-1 is observed in about 30% of myelodysplastic syndrome (MDS) and subsequent leukemia cases.
Purpose:
- To investigate alternative mechanisms of IRF-1 inactivation in leukemia.
- To identify proteins that interact with and modulate IRF-1 activity.
Summary:
- A novel IRF-1 binding protein (IRF-BP) was identified and found to be identical to nucleophosmin (NPM).
- IRF-BP inhibits the DNA-binding and transcriptional activity of IRF-1.
- Increased levels of IRF-BP mRNA were detected in leukemia samples, suggesting its role in disease progression.
- Overexpression of IRF-BP in NIH 3T3 cells resulted in cellular transformation, supporting its oncogenic potential.
Impact:
- These findings suggest that NPM-mediated inactivation of IRF-1 is a mechanism for escaping IRF-1-regulated growth control in leukemias.
- This discovery provides a potential therapeutic target for MDS and leukemia by addressing IRF-1 dysregulation.
